Introduction
The term mixed connective tissue disease (MCTD) was proposed by Sharp et al. (1972) for a disease entity combining, in varying proportions, features of systemic lupus erythematosus (SLE), progressive systemic sclerosis (PSS) and polymyositis. This syndrome is characterized by the presence of a saline extractable nuclear antigen (ENA) believed to be predominantly ribonucleoprotein (RNP) and sensitive to ribonuclease (RNAase) digestion. Other findings include a strongly positive anti-nuclear factor (ANF) exhibiting a speckled immunofluorescent pattern and with normal DNA binding. Serum complement levels are usually normal or elevated, renal involvement believed rare. It has been considered to run a more benign course than SLE or systemic sclerosis alone and, unlike the latter, shows a good response to steroids. Described here is a case of MCTD with histologically-proved associated glomerulonephritis and persistent hypocomplementaemia. In the light of these findings mixed connective tissue disease was suspected and an extractable nuclear antigen (ENA) consisting entirely of RNP sensitive to RNAase digestion was found to be positive confirming the clinical diagnosis.
Her condition rapidly improved in hospital on symptomatic treatment and she was allowed home. After one month another practitioner prescribed prednisolone at an initial dose of 10 mg/day rapidly reducing to nil over 2 weeks, on which she further improved.
In 
Discussion
This further adds to evidence reported from several American centres (Bennett and Spargo, 1977; Farber and Bole, 1975; Fuller et al., 1977; Hench, Edgington and Tan, 1975; Leibfarth, McChesney and Persellin, 1975; Tan, Northway and Pinnas, 1973; Venkateswara et al., 1976) and recently from Paris (Gaudreau et al., 1978) that renal involvement does occur in MCTD. The case reported here is all the more unusual as, of those reported cases, only that by Fuller et al. (1977) was definitely associated with hypocomplementaemia, the usual finding being normal or raised complement levels.
In keeping with other connective tissue disorders renal biopsy specimens in MCTD have not shown a constant histological pattern. Of those reported membranous glomerulonephritis was recognized in 3 cases by Bennett and Spargo (1977) and one case each by Hench et al. (1975) and Fuller et al. (1977) although the latter also contained some focal mesangial proliferative changes. Venkateswara et al. (1976) reported a case with focal mesangial proliferative changes, and single cases of Leibfarth et al. (1975) and Tan et al. (1973) revealed focal proliferative and proliferative glomerulonephritic changes respectively. All these cases had glomerular deposits of complement and immunoglobulin.
It is perhaps too early to assess the significance of glomerulonephritis in MCTD as the number of cases has been small and this syndrome only accepted as a distinct entity since the original description of 25 cases by Sharp et al., in Feburary 1972 . In this initial description, however, it was considered that ENA may exert a renal protective role. This was based on the finding in an earlier study by Sharp et al. (1971) that renal involvement in SLE was less aggressive and more amenable to treatment in the presence of ENA. Since then it has been shown that ENA consists of at least 2 main components, namely Sm* and RNP. As it is the latter which is present in MCTD and the former more often in SLE, the precise role of these components with regard to renal disease is therefore unclear.
MCTD is nonetheless still considered as carrying * Smith a better prognosis than any of its single constituents despite the acceptance of the occurrence of renal disease. The significance of the glomerulonephritis may only be known, therefore, with longer term follow-up of cases and increased recognition of this syndrome.
A further point of interst in the case described here is of presumed SLE in 2 sisters. Recent observations have suggested a familial association of MCTD with SLE (Sharp, 1971 ) and in one family MCTD was diagnosed in 2 siblings with identical HLA genotypes (Horn, Kapur and Walker, 1978) .
Finally, the response to steroids of the PSS component of this syndrome is well illustrated here by the significant improvement in respiratory function in lung biopsy-proved systemic sclerosis. 
